{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:06:54Z","timestamp":1788883614217,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omtn.2026.102988","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:58:29Z","timestamp":1781711909000},"page":"102988","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimizing twin prime editing components for scalable genome editing and therapy in spinocerebellar ataxia type 3"],"prefix":"10.1016","volume":"37","author":[{"given":"Lee Wha","family":"Gwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Bae","family":"Seong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon-Gu","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeounsun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junghyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyoung","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Je","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-won","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aryun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang-Hyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngjeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0856-8023","authenticated-orcid":false,"given":"Seung Hwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.102988_bib1","first-page":"1076","article-title":"Past, present, and future of CRISPR genome editing technologies","volume":"187","author":"Pacesa","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.102988_bib2","first-page":"816","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.102988_bib3","first-page":"824","article-title":"Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.102988_bib4","first-page":"149","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.102988_bib5","first-page":"161","article-title":"Prime editing for precise and highly versatile genome manipulation","volume":"24","author":"Chen","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtn.2026.102988_bib6","article-title":"Recent advances in prime editing technologies and their promises for therapeutic applications","volume":"86","author":"Zeng","year":"2024","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.omtn.2026.102988_bib7","article-title":"Directed evolution of hyperactive integrases for site specific insertion of transgenes","volume":"52","author":"Hew","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102988_bib8","first-page":"22","article-title":"Efficient site-specific integration of large genes in mammalian cells via continuously evolved recombinases and prime editing","volume":"9","author":"Pandey","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.omtn.2026.102988_bib9","first-page":"500","article-title":"Drag-and-drop genome insertion of large sequences without double-strand DNA cleavage using CRISPR-directed integrases","volume":"41","author":"Yarnall","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.102988_bib10","first-page":"224","article-title":"Structural basis for pegRNA-guided reverse transcription by a prime editor","volume":"631","author":"Shuto","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.102988_bib11","first-page":"5635","article-title":"Enhanced prime editing systems by manipulating cellular determinants of editing outcomes","volume":"184","author":"Chen","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.102988_bib12","first-page":"3983","article-title":"Phage-assisted evolution and protein engineering yield compact, efficient prime editors","volume":"186","author":"Doman","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.102988_bib13","first-page":"639","article-title":"Improving prime editing with an endogenous small RNA-binding protein","volume":"628","author":"Yan","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.102988_bib14","first-page":"402","article-title":"Engineered pegRNAs improve prime editing efficiency","volume":"40","author":"Nelson","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.102988_bib15","first-page":"731","article-title":"Programmable deletion, replacement, integration and inversion of large DNA sequences with twin prime editing","volume":"40","author":"Anzalone","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.102988_bib16","first-page":"374","article-title":"Twin prime editor: seamless repair without damage","volume":"40","author":"Awan","year":"2022","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.omtn.2026.102988_bib17","first-page":"2764","article-title":"Twin Prime Editing Mediated Exon Skipping\/Reinsertion for Restored Collagen VII Expression in Recessive Dystrophic Epidermolysis Bullosa","volume":"144","author":"Steinbeck","year":"2024","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.omtn.2026.102988_bib18","first-page":"6423","article-title":"Bi-PE: bi-directional priming improves CRISPR\/Cas9 prime editing in mammalian cells","volume":"50","author":"Tao","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102988_bib19","first-page":"218","article-title":"Precise genomic deletions using paired prime editing","volume":"40","author":"Choi","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.102988_bib20","first-page":"1902","article-title":"Advances in large-scale DNA engineering with the CRISPR system","volume":"57","author":"Gwon","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.omtn.2026.102988_bib21","article-title":"In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy","volume":"8","author":"Han","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtn.2026.102988_bib22","first-page":"439","article-title":"Successful correction of hemophilia by CRISPR\/Cas9 genome editing in vivo: delivery vector and immune responses are the key to success","volume":"8","author":"Nguyen","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omtn.2026.102988_bib23","first-page":"213","article-title":"Functional Correction of Large Factor VIII Gene Chromosomal Inversions in Hemophilia A Patient-Derived iPSCs Using CRISPR-Cas9","volume":"17","author":"Park","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtn.2026.102988_bib24","first-page":"543","article-title":"Customizable virus-like particles deliver CRISPR-Cas9 ribonucleoprotein for effective ocular neovascular and Huntington's disease gene therapy","volume":"20","author":"Ling","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.omtn.2026.102988_bib25","first-page":"829","article-title":"CRISPR-Cas9-Mediated Genome Editing Increases Lifespan and Improves Motor Deficits in a Huntington's Disease Mouse Model","volume":"17","author":"Ekman","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.102988_bib26","first-page":"10785","article-title":"Optimized nickase- and nuclease-based prime editing in human and mouse cells","volume":"49","author":"Adikusuma","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102988_bib27","first-page":"1473","article-title":"Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases","volume":"30","author":"Bae","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtn.2026.102988_bib28","article-title":"Spinocerebellar ataxias: from pathogenesis to recent therapeutic advances","volume":"18","author":"Cui","year":"2024","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.omtn.2026.102988_bib29","first-page":"8","article-title":"Machado-Joseph disease\/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy","volume":"148","author":"Matos","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.omtn.2026.102988_bib30","first-page":"232","article-title":"Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice","volume":"8","author":"Toonen","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.102988_bib31","first-page":"3908","article-title":"AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102988_bib32","first-page":"353","article-title":"Highly specific chimeric DNA-RNA-guided genome editing with enhanced CRISPR-Cas12a system","volume":"28","author":"Kim","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.102988_bib33","first-page":"276","article-title":"Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing","volume":"37","author":"Kleinstiver","year":"2019","journal-title":"Nat. Biotechnol."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126001599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126001599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:10:38Z","timestamp":1788880238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253126001599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2162253126001599"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102988","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing twin prime editing components for scalable genome editing and therapy in spinocerebellar ataxia type 3","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102988","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102988"}}